92 related articles for article (PubMed ID: 23968400)
1. Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects.
Saddi-Rosa P; Oliveira C; Crispim F; Giuffrida FM; de Lima V; Vieira J; Doria A; Velho G; Reis A
Cardiovasc Diabetol; 2013 Aug; 12():119. PubMed ID: 23968400
[TBL] [Abstract][Full Text] [Related]
2. The interplay between extracellular NAMPT and inflammatory cytokines in preeclampsia.
Nunes PR; Pereira DA; Passeti LFP; Coura LLF; Gomes KB; Sandrim VC; Luizon MR
J Reprod Immunol; 2024 Jun; 163():104248. PubMed ID: 38703439
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum adipokines (omentin-1 and visfatin) in coronary artery disease at a North Indian hospital.
Ali S; Alam R; Ahmad MK; Ahmad M; Ahsan H; Khan MM; Khan S
Endocr Regul; 2023 Jan; 57(1):262-268. PubMed ID: 38127689
[No Abstract] [Full Text] [Related]
4. Linkage of NAMPT promoter variants to eNAMPT secretion, plasma eNAMPT levels, and ARDS severity.
Lynn H; Sun X; Casanova NG; Bime C; Reyes Hernon V; Lanham C; Oita RC; Ramos N; Sun B; Coletta DK; Camp SM; Karnes JH; Ellis NA; Garcia JGN
Ther Adv Respir Dis; 2023; 17():17534666231181262. PubMed ID: 37477094
[TBL] [Abstract][Full Text] [Related]
5. Dangua Fang regulating tricarboxylic acid cycle and respiratory chain and its mechanism in diabetic rats.
Xianpei H; Zhita W; Liuqing Y; Liang LI; Suping H
J Tradit Chin Med; 2023 Oct; 43(6):1150-1159. PubMed ID: 37946477
[TBL] [Abstract][Full Text] [Related]
6. Association of -2518A>G promoter polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with type 2 diabetes and coronary artery disease.
Kaur R; Matharoo K; Arora P; Bhanwer AJ
Genet Test Mol Biomarkers; 2013 Oct; 17(10):750-5. PubMed ID: 23930970
[TBL] [Abstract][Full Text] [Related]
7. LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.
Santos PC; Bueno CT; Lemos PA; Krieger JE; Pereira AC
Lipids Health Dis; 2014 Apr; 13():74. PubMed ID: 24776095
[TBL] [Abstract][Full Text] [Related]
8. Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker.
Semerena E; Nencioni A; Masternak K
Front Immunol; 2023; 14():1268756. PubMed ID: 37915565
[TBL] [Abstract][Full Text] [Related]
9. eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes.
Gao L; Ramirez FJ; Cabrera JTO; Varghese MV; Watanabe M; Tsuji-Hosokawa A; Zheng Q; Yang M; Razan MR; Kempf CL; Camp SM; Wang J; Garcia JGN; Makino A
Diabetologia; 2024 Jun; ():. PubMed ID: 38898303
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic role of NAMPT in the perivascular regions after ischemic stroke in mice with type 2 diabetes mellitus.
Iwatani Y; Hayashi H; Yamamoto H; Minamikawa H; Ichikawa M; Orikawa H; Masuda A; Tada N; Moriyama Y; Takagi N
Exp Neurol; 2024 Jan; 371():114584. PubMed ID: 37884188
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of Nε-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients.
Shrivastav D; Singh DD; Mir R; Mehra P; Mehta V; Dabla PK
World J Diabetes; 2023 Dec; 14(12):1754-1765. PubMed ID: 38222780
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of polygenic scores for cardiometabolic disease in Arabs.
Shim I; Kuwahara H; Chen N; Hashem MO; AlAbdi L; Abouelhoda M; Won HH; Natarajan P; Ellinor PT; Khera AV; Gao X; Alkuraya FS; Fahed AC
Nat Commun; 2023 Oct; 14(1):6535. PubMed ID: 37852978
[TBL] [Abstract][Full Text] [Related]
13. Postmortem Alteration of Purine Metabolism in Coronary Artery Disease.
Somtua P; Jaikang C; Konguthaithip G; Intui K; Watcharakhom S; O'Brien TE; Amornlertwatana Y
Metabolites; 2023 Nov; 13(11):. PubMed ID: 37999231
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-Ribose) Polymerase Activity and Coronary Artery Disease in Type 2 Diabetes Mellitus: An Observational and Bidirectional Mendelian Randomization Study.
Cui NH; Yang JM; Liu X; Wang XB
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2516-2526. PubMed ID: 32757651
[TBL] [Abstract][Full Text] [Related]
15. Correlation Analysis of NAMPT rs61330082 Polymorphism in Type 2 Diabetes Mellitus Combined with Hypertension.
Zuo C; Liu Y; Wang Z; Cheng J; Yang D; Gong H; Wang Y; Qiao Y
Diabetes Metab Syndr Obes; 2024; 17():1809-1818. PubMed ID: 38650633
[TBL] [Abstract][Full Text] [Related]
16. Visfatin is negatively associated with coronary artery lesions in subjects with impaired fasting glucose.
Xu F; Ning X; Zhao T; Lu Q; Chen H
Open Med (Wars); 2022; 17(1):1405-1411. PubMed ID: 36128447
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Serum Biomarkers in Patients with Sarcoidosis: Can Visfatin Be a New Biomarker for Sarcoidosis?
Tanrıverdi E; İliaz S; Cortuk M; Turan D; Chousein EGU; Gül Ş; Özgül MA; Çetinkaya E; Kirankaya A
Turk Thorac J; 2020 May; 21(3):145-149. PubMed ID: 32584229
[TBL] [Abstract][Full Text] [Related]
18. Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction.
Zheng M; Lu N; Ren M; Chen H
BMC Cardiovasc Disord; 2020 Jun; 20(1):271. PubMed ID: 32503436
[TBL] [Abstract][Full Text] [Related]
19. Variations in the
Rong J; Chu M; Xing B; Zhu L; Wang S; Tao T; Zhao Y; Jiang L
Meta Gene; 2015 Dec; 6():65-68. PubMed ID: 30941280
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel Regulatory Genes in APAP Induced Hepatocyte Toxicity by a Genome-Wide CRISPR-Cas9 Screen.
Shortt K; Heruth DP; Zhang N; Wu W; Singh S; Li DY; Zhang LQ; Wyckoff GJ; Qi LS; Friesen CA; Ye SQ
Sci Rep; 2019 Feb; 9(1):1396. PubMed ID: 30718897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
